Predictors of QOL in Patients with Alopecia Areata

被引:22
|
作者
Senna, Maryanne [1 ]
Ko, Justin [2 ]
Glashofer, Marc [3 ]
Walker, Chloe [1 ]
Ball, Susan [4 ]
Edson-Heredia, Emily [4 ]
Zhu, Baojin [4 ]
Shapiro, Jerry [5 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[3] Dermatol Grp, W Orange, NJ USA
[4] Eli Lilly & Co, Indianapolis, IN 46285 USA
[5] NYU, Ronald O Perelman Dept Dermatol, New York, NY USA
关键词
QUALITY-OF-LIFE;
D O I
10.1016/j.jid.2022.02.019
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Although alopecia areata (AA) severity is often defined by the degree of scalp hair loss, its impact on QOL can also be a defining measure of severity. In this cross-sectional study (AA Disease Specific Program), 259 patients were surveyed for demographics, AA illness characteristics, QOL (Skindex-16 AA), and daily impairment (Work Productivity and Activity Impairment). The association between patient demographics and illness variables, the Skindex-16 AA scores, and the Work Productivity and Activity Impairment scores were analyzed using regression analyses. The mean age of patients was 39 years (51% female). Self-reported severity of current AA was rated as mild (21%), moderate (54%), and severe (25%). The highest impairment was observed for the Skindex-16 AA emotions and the Work Productivity and Activity Impairment daily activity performance scores. Although the degree of scalp hair loss (physician Severity of Alopecia Tool score) was not predictive of QOL, patients' self-report of moderate or severe disease, sex (females more impacted), and eyebrow and eyelash involvement were predictors of diminished QOL, consistently and incrementally. The present results suggest patients' perception of severity as well as the presence of eyelash and eyebrow hair loss are also impactful and should be considered in defining the severity of disease.
引用
收藏
页码:2646 / +
页数:8
相关论文
共 50 条
  • [21] Safety of baricitinib in patients with alopecia areata
    Bissonnette, Robert
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188 (02) : 165 - 165
  • [22] Electrocardiogram Findings in Patients with Alopecia Areata
    Peterson, Danielle
    Wambier, Carlos
    Dai, Feng
    Lampert, Rachel
    Ahmad, Tariq
    Yale, Katerina L.
    Mesinkovska, Natasha A.
    King, Brett
    DERMATOLOGY AND THERAPY, 2021, 11 (06) : 2217 - 2223
  • [23] Stress in patients with alopecia areata and vitiligo
    Manolache, Liana
    Benea, Vasile
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2007, 21 (07) : 921 - 928
  • [24] Comparison of quality of life in patients with androgenetic alopecia and alopecia areata
    Gonul, Muzeyyen
    Cemil, Bengu Cevirgen
    Ayvaz, Havva Hilal
    Cankurtaran, Eylem
    Ergin, Can
    Gurel, Mehmet Salih
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2018, 93 (05) : 651 - 658
  • [25] Predictors and Management of Inadequate Response to JAK Inhibitors in Alopecia Areata
    Zhang, Xiaolin
    Jiang, Yiqun
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (06) : 975 - 986
  • [26] Predictors of Vitamin D Insufficiency in Children and Adolescents With Alopecia Areata
    Lim, Rachel K.
    Castelo-Soccio, Leslie
    Putterman, Elana
    Qureshi, Abrar A.
    Cho, Eunyoung
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [27] Illness perception in patients with androgenetic alopecia and alopecia areata in China
    Yu, Nan-Lan
    Tan, Huan
    Song, Zhi-Qiang
    Yang, Xi-Chuan
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2016, 86 : 1 - 6
  • [28] Alopecia areata
    Hoffmann, R
    Happle, R
    HAUTARZT, 1999, 50 (03): : 222 - 231
  • [29] Alopecia areata
    Marta Bujan, Maria
    Bocian, Marcela
    Bettina Cervini, Andrea
    Martin Pierini, Adrian
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2013, 111 (05): : 455 - 456
  • [30] ALOPECIA AREATA
    不详
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1955, 158 (13): : 1237 - 1237